| 从指南看冠心病降脂治疗的现状及分析 |
| |
| 引用本文： | 颜雯,赵水平.从指南看冠心病降脂治疗的现状及分析[J].医学与哲学,2006,27(4):56-59. |
| |
| 作者姓名： | 颜雯 赵水平 |
| |
| 作者单位： | 中南大学湘雅二医院心血管内科 湖南长沙410011 |
| |
| 摘 要： | 层出不穷的试验研究和不断更新的指南使人们对冠心病防治的认识不断加深,但指南的实施和普及却不理想,大多数冠心病患者并未真正受益于降脂治疗。现就NCEP-ATP指南的更新和目前冠心病患者降脂治疗的现状、主要影响因素(患者的依从性、医务工作者的医疗质量、药物有效性以及效价比与经济条件)及可能的改善措施做一综述。
|
| 关 键 词： | 冠心病 降脂治疗 NCEP-ATPIII 治疗指南 影响因素 |
| 文章编号： | 1002-0772（2006）04-0056-04 |
| 收稿时间： | 2006-03-07 |
| 修稿时间： | 2006-03-07 |
Beyond Guidelines:the current situation of lipid-lowering therapy in patients with coronary heart disease |
| |
| YAN Wen, ZHAO Shui-ping..Beyond Guidelines:the current situation of lipid-lowering therapy in patients with coronary heart disease[J].Medicine & Philosophy:Humanistic & Social Medicine Edition,2006,27(4):56-59. |
| |
| Authors: | YAN Wen ZHAO Shui-ping |
| |
| Institution: | The Second Affiliated Hospital of Xiangya , Central South University, Changsha 410011, China |
| |
| Abstract: | Recently,lots of experiments help us to know more about the prevention and care of coronary heart disease,with which treatment guidelines update times and become more clear. However,a major part of the population is not achieving the recommended LDL cholesterol target levels. This fact is more prominent among high-risk populations in which the majority of patients are untreated or under-treated. The review will present the new changes of the treatment guidelines,elaborate on the current situation of lipid-lowering therapy of coronary heart disease and its key influencing factors: patient compliance,drug efficacy,cost-benefit,and physician quality of care. A programme aimed at improving control of hyperlipidemia should address all these four issues. |
| |
| Keywords: | coronary heart disease lipid-lowering therapy NCEP-ATPIII treatment guidelines lnfluencing factors |
| 本文献已被 CNKI 维普 等数据库收录！ |
